How to use (dosage) GLP-1 agonists are typically injected subcutaneously, with some oral options like Rybelsus available
Who should not take GLP-1s While GLP-1s can be safe and effective for many people, they arent right for everyone
Extraction of data Data from the trials, including the name of the principal investigator, the year of publication, the sample size, and the research design, were extracted using a pre-made template
Long-term human trial data also confirms a favorable safety profile, with most adverse events such as nausea and headache being mild and transient in nature
Whilst effective for glycaemic control, constipation is a commonly reported side effect due to delayed gastric emptying and reduced gut motility